Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-23-000862

Options or other derivatives

  • Chief Executive Officer acquired 5,236 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Finley John David Chief Executive Officer 2023-01-03 Grant or award · Restricted Stock Units +5,236 5,236 D
Loading xslF345X03/ownership.xml…